The Royal Pharmaceutical Society (RPS) strongly supports the MHRA’s decision to licence all nicotine-containing products, including e-cigarettes, as medicines to help people cut down or stop smoking.
RPS spokesperson Neal Patel said:
“This decision will put an end to the dodgy pop-up shops selling e-cigarettes made who knows where to unknown standards which could cause real health problems. ”
Further reading available here: http://www.rpharms.com/pressreleases/pr_show.asp?id=876